MISSION Appoints Paul Wallace as Chief Business Officer
Appointment highlights scope and productivity of drug discovery platform Cambridge, UK, March 16, 2015 / B3C newswire / -- MISSION Therapeutics, a company focused on the discovery and development of modulators of the deubiquitylating (DUB) enzyme family …